Literature DB >> 12649768

Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats.

K Isogawa1, M Fujiki, J Akiyoshi, T Tsutsumi, Y Horinouchi, K Kodama, H Nagayama.   

Abstract

Repetitive transcranial magnetic stimulation (rTMS) has been shown to have a therapeutic effect on affective disorder and anxiety disorders. However, some reports have linked rTMS to a significant increase in anxiety in normal volunteers. This study investigates the effect of rTMS on anxiety and the use of acute and chronic paroxetine treatment on this animal model of anxiety. In normal rats, rTMS for 10 days induced anxiety, as shown by elevated plus maze, black and white box, and conditioned fear tests. This anxiety was suppressed by chronic, but not acute, paroxetine. These results suggest that rats receiving chronic rTMS treatment can be used as a model of anxiety and that the anxiety induced by rTMS might involve the serotonergic system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649768     DOI: 10.1055/s-2003-38085

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  4 in total

Review 1.  Anxiolytic effects of transcranial magnetic stimulation--an alternative treatment option in anxiety disorders?

Authors:  Peter Zwanzger; A J Fallgatter; M Zavorotnyy; F Padberg
Journal:  J Neural Transm (Vienna)       Date:  2009-01-10       Impact factor: 3.575

Review 2.  Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats.

Authors:  Andrew M Vahabzadeh-Hagh; Paul A Muller; Roman Gersner; Abraham Zangen; Alexander Rotenberg
Journal:  Neuromodulation       Date:  2012-07-10

Review 3.  Extremely Low-Frequency Magnetic Field as a Stress Factor-Really Detrimental?-Insight into Literature from the Last Decade.

Authors:  Angelika Klimek; Justyna Rogalska
Journal:  Brain Sci       Date:  2021-01-31

4.  The alkaloid alstonine: a review of its pharmacological properties.

Authors:  E Elisabetsky; L Costa-Campos
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-16       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.